Monday, 16 January 2017

Attorney Bernard Walsh comments on the FTC's decision to charge jellyfish memory supplement makers with fraud

Bernard Walsh, of Shapiro Goldman Babboni Fernandez and Walsh, has commented on the Federal Trade Commission's decision to charge supplement maker Quincy Bioscience with fraud.

from Government - United States - Latest News http://ift.tt/2jBImSf
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)